Published in Dermatologica on January 01, 1981
Light-induced protoporphyrin release from erythrocytes in erythropoietic protoporphyria. J Clin Invest (1982) 0.75
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet (1996) 2.36
The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet (1998) 1.99
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89
Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet (1999) 1.81
Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat Res (1991) 1.74
Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther (1990) 1.73
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet (2000) 1.64
High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet (1999) 1.60
Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature (1981) 1.56
Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet (2000) 1.56
Interactions between exogenous deoxyribonucleic acid and membrane vesicles isolated from competent and noncompetent Bacillus subtilis. J Bacteriol (1975) 1.55
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet (2000) 1.51
The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet (2000) 1.48
Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res (1992) 1.43
Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet (1995) 1.43
Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res (1988) 1.42
Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res (1990) 1.39
Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories. Dermatologica (1990) 1.38
Different nuclease activities in competent and noncompetent Bacillus subtilis. J Bacteriol (1975) 1.37
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci U S A (1999) 1.32
The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci U S A (1998) 1.30
Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res (1995) 1.29
Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood (2000) 1.29
Interactions between exogenous deoxyribonucleic acid and membrane vesicles isolated from Bacillus subtilis 168. J Bacteriol (1974) 1.26
Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. J Natl Cancer Inst (1989) 1.23
Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res (1989) 1.22
Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure. Somat Cell Mol Genet (1996) 1.20
Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood (1996) 1.11
Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology (1986) 1.09
Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol (1992) 1.09
Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A (2001) 1.07
Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet (1996) 1.06
[Increasing frequency of ulcus molle]. Ned Tijdschr Geneeskd (1977) 1.06
Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol (1996) 1.05
Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer. Mol Med (1998) 1.03
Stimulation of the development of competence by culture fluids in Bacillus subtilis transformation. Biochim Biophys Acta (1972) 1.02
The Fanconi anemia group E gene, FANCE, maps to chromosome 6p. Am J Hum Genet (1999) 1.02
Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer (1996) 1.00
Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest (1993) 0.99
Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis (1994) 0.97
Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food Chem Toxicol (1991) 0.97
Immunohistopathology of light-induced skin lesions in lupus erythematosus. Acta Derm Venereol (1990) 0.97
Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia. J Biol Chem (1990) 0.96
Inability of chemically generated singlet oxygen to break the DNA backbone. Free Radic Res Commun (1985) 0.96
Respiratory tract tumours in hamsters exposed to acetaldehyde vapour alone or simultaneously to benzo(a)pyrene or diethylnitrosamine. Eur J Cancer Clin Oncol (1982) 0.95
Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res (1999) 0.95
Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology (1990) 0.94
Mutational specificity of oxidative DNA damage. Mutat Res (1993) 0.93
An atypical case of Fanconi anemia in elderly sibs. Am J Med Genet (1997) 0.93
Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. Eur J Hum Genet (2000) 0.93
Interaction of singlet oxygen with DNA and biological consequences. Mutat Res (1992) 0.93
Mutations of the Fanconi anemia group A gene (FAA) in Italian patients. Am J Hum Genet (1997) 0.93
Inhalation toxicity of acetaldehyde in rats. I. Acute and subacute studies. Toxicology (1982) 0.93
Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol (1997) 0.92
Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action. Food Chem Toxicol (1997) 0.92
Light-induced skin lesions in lupus erythematosus: photobiological studies. Arch Dermatol Res (1989) 0.92
Subacute (4-wk) oral toxicity of a combination of four nephrotoxins in rats: comparison with the toxicity of the individual compounds. Food Chem Toxicol (1993) 0.92
Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology (1989) 0.90
Hyperoxia-induced clonogenic killing of HeLa cells associated with respiratory failure and selective inactivation of Krebs cycle enzymes. Mutat Res (1990) 0.90
Fragile sites and chromosome instability: the distribution of breaks induced by cis-diamine-dichloro-platinum (II) in Fanconi anemia lymphocyte cultures. Hum Genet (1991) 0.90
Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mamm Genome (2000) 0.90
Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol (2001) 0.90
Blood exchange and transfusion therapy for acute cholestasis in protoporphyria. Dig Dis Sci (1988) 0.89
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Cell Oncol (2008) 0.89
Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol (1989) 0.89
Differential sensitivity of Fanconi anaemia lymphocytes to the clastogenic action of cis-diamminedichloroplatinum (II) and trans-diamminedichloroplatinum (II). Hum Genet (1985) 0.89
Unusual response to bifunctional alkylating agents in a case of Fanconi anaemia. Hum Genet (1983) 0.88
An immunohistochemical study of the skin of healthy individuals. Acta Derm Venereol (1974) 0.88
Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis (1991) 0.88
Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells. Blood (1997) 0.88
In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies. Ann Rheum Dis (1990) 0.87
Expression profiling of colon cancer cell lines and colon biopsies: towards a screening system for potential cancer-preventive compounds. Eur J Cancer Prev (2005) 0.86
Effects of dietary linoleic acid on pancreatic carcinogenesis in rats and hamsters. Cancer Res (1994) 0.86
Acute (24 hr) toxicity of a combination of four nephrotoxicants in rats compared with the toxicity of the individual compounds. Food Chem Toxicol (1993) 0.85
Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase. Cancer Res (1997) 0.85
Carcinogenic response of the nasal cavity to inhaled chemical mixtures. Mutat Res (1997) 0.85
Antioxidant status of Fanconi anemia fibroblasts. Hum Genet (1987) 0.85
Modulation of putative preneoplastic foci in exocrine pancreas of rats and hamsters. I. Interaction of dietary fat and ethanol. Carcinogenesis (1986) 0.85
4-week oral toxicity study of a combination of eight chemicals in rats: comparison with the toxicity of the individual compounds. Food Chem Toxicol (1990) 0.85
A low molecular weight DNA polymerase from ovaries of the frog Xenopus laevis. DNA polymerase-beta (ovarian). J Biol Chem (1978) 0.85
Chromosomal instability and progressive loss of chromosomes in HeLa cells during adaptation to hyperoxic growth conditions. Mutat Res (1989) 0.84
Inhalation toxicity of acetaldehyde in rats. II. Carcinogenicity study: interim results after 15 months. Toxicology (1984) 0.84
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol (2000) 0.84
Subchronic (13-week) inhalation toxicity study of formaldehyde in rats. J Appl Toxicol (1987) 0.84
Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines. Cancer Res (1992) 0.84
Nasal tumours in rats after short-term exposure to a cytotoxic concentration of formaldehyde. Cancer Lett (1988) 0.84
Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol (1988) 0.84
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res (1989) 0.83
Adenosine triphosphatase, a new marker for the differentiation of putative precancerous foci induced in rat pancreas by azaserine. Carcinogenesis (1986) 0.83
Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis (1990) 0.83
Photosensitivity caused by chloroquine. Arch Dermatol (1982) 0.83
Characterization of a 4-month protocol for the quantitation of BOP-induced lesions in hamster pancreas and its application in studying the effect of dietary fat. Carcinogenesis (1987) 0.82
Localisation of a Fanconi anaemia gene to chromosome 9p. Eur J Hum Genet (1999) 0.82
One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J Appl Toxicol (1988) 0.82
Evaluation of the oral toxicity of acetaldehyde and formaldehyde in a 4-week drinking-water study in rats. Food Chem Toxicol (1988) 0.82
Chenodeoxycholic acid therapy in erythrohepatic protoporphyria. J Hepatol (1986) 0.82
Fanconi anemia complementation group E: clinical and cytogenetic data of the first patient. Clin Genet (1996) 0.82